Navigation Links
Milestone Scientific Inc. Commences Trading on the OTC Pink

LIVINGSTON, N.J., March 14 , 2011 /PRNewswire/ -- Milestone Scientific Inc. (Pink Sheets: MLSS) which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK.  Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).

The OTCQB(TM) marketplace was created in 2010 by Pink OTC Markets Inc. as a special tier of the OTC market to better distinguish companies that are registered and reporting with U.S. regulators from non-reporting companies.  Pink OTC Markets makes Real-Time Level 2 market maker quotations for all OTCQB securities available to investors on  Pink OTC Markets Inc. now operates the leading electronic interdealer quotation and trading system and facilitates trading in over 9,000 securities not listed on a U.S. stock exchange.

The Company's securities are no longer being quoted by any market maker on the OTC Bulletin Board operated by Financial Regulatory Authority, Inc. (FINRA). The OTCBB(TM) is a quotation service for FINRA market makers and not an issuer listing service or securities market.

The OTCQB(TM) and the OTCBB(TM) are competing inter-dealer quotation systems. Although the securities of some companies are still quoted on both systems, there has recently been a substantial migration of trading volume from the OTCBB(TM) to the OTCQB(TM) for technology, cost, and service reasons. The OTCQB(TM) is widely viewed as superior to the OTCBB(TM) by market makers and issuers because the OTCBB(TM) does not support electronic trading and does not offer issuer services to its quoted companies.

Milestone Scientific Inc.

Milestone Scientific, the recognized leader in advanced injection technologies, is engaged in pioneering proprietary, innovative, technological solutions for the medical and dental markets.  Central to the Company's IP platform and product development strategy is its patented CompuFlo® technology for the improved and painless delivery of local anesthetic.  Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids.  The STASingle Tooth Anesthesia System(TM), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure.  Milestone's existing painless injection instruments are currently sold in 25 countries.  For more information on these and other innovative Milestone products, please visit the Company's web site found at and

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. They are based upon management's reasonable belief as of the date hereof.

For additional information, please contact:

Leonard Osser, CEO, at (973) 535-2717

SOURCE Milestone Scientific Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
3. AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the NIH to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedys Disease)
4. Canadian Pharmacy Intermediary Celebrates Milestone
5. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
6. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
7. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
8. FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
9. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
10. Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
11. JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
Breaking Medicine Technology:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):